Glofitamab,Atezolizumab,Polatuzumab Vedotin,Obinutuzumab,Tocilizumab,89Zr-Df-IAB22M2C
Roche,Imaginab,JW Pharma
['pola', 'dlbcl', 'polatuzumab', 'glofitamab']
#17icml . martin hutching presenting glofitamab plus polatuzumab phase 1&amp;2 in dlbcl. 
Happily married. Hematologist & SC Transplanter. field of interest: lymphoma-myeloma &chemoresistance biomarkers. @HematoClinicBCN @hematosantpau.@GELL01433166